[Histonet] Histology in the news....

[Morken, Tim]

Along with the new CAP/ASCO ER/PR guidelines there was a front page article in the NY Times yesterday: "Cancer Fight: Unclear Tests for New Drug." It details the issues with interpreting Her2 staining and the continuing issue with disparate results from different labs when doing ER, PR and Her2 testing on the same sample. Nothing new to those in the field, but we are under continued scrutiny so better be sure your validation procedures are in order!!

Tim Morken
Supervisor, Histology / IHC
UCSF Medical Center
San Francisco, CA